Research interests

Complement activation in COVID-19

specialisation

Intensive Care Medicine

Research output

  1. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

    Research output: Contribution to journal › Article › Academic › peer-review

  3. EXpert consensus On Diaphragm UltraSonography in the critically ill (EXODUS): a Delphi consensus statement on the measurement of diaphragm ultrasound-derived parameters in a critical care setting

    Research output: Contribution to journal › Article › Academic › peer-review

View all (9) »

Projects

  1. Complement activation in COVID-19

    Project: Research

View all () »

ID: 13105013